Back

Effects of intensive blood pressure control across the spectrum of renal impairment: a post hoc analysis from ESPRIT

30 August 2026 (08:45 - 08:55)
Organised by: Logo
Congress Presentation Part of: Treatment of hypertension Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Shitian Li

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Zilebesiran in combination with a diuretic in patients with uncontrolled hypertension: a subgroup analysis from the Phase 2 KARDIA-3 trial
Doctor N. Pagidipati (Durham, US)
Abstract Slides
Presentation thumbnail
Heart failure and uncontrolled hypertension: recent evidence of routine care in Germany
Professor J. Weil (Luebeck, DE)
Abstract Slides
Presentation thumbnail
Effects of a novel low-dose triple combination on blood pressure variability: results from the TRIDENT trial
Doctor T. Wang (Sydney, AU)
Abstract Slides
Presentation thumbnail
Differences of the characteristics of uncontrolled versus controlled hypertensive patients, treated with at least three antihypertensive drugs: insights from the SNAPSHOT Europe study
Professor M. Camafort (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Efficacy and safety of potassium-enriched salt substitutes in hypertension management: a systematic review and meta-analysis
Mr T. Bonafe (Varzea Grande, BR)
Abstract Slides

Access the full session

Session thumbnail
Treatment of hypertension
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 08:45 CET
You may be interested in
thumbnail
Congress Presentation
Renal function and intensive blood pressure lowering in high-risk adults without diabetes: insights from the Systolic Blood Pressure Intervention Trial (SPRINT)
3 September 2019
thumbnail
Congress Presentation
Effect of intensive blood pressure control on stroke: a pre-specified secondary analysis of the ESPRIT trial
30 August 2025
thumbnail
Congress Presentation
Effect of blood pressure reduction on cardiovascular outcomes in patients with different baseline cardiovascular risk: systematic review and meta-analysis of randomized trials
28 August 2022
thumbnail
Congress Presentation
Long-term outcomes after renal denervation in the two defined ESC guideline-recommended patient groups: an analysis from the Global SYMPLICITY Registry DEFINE
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources